In the pharmaceutical industry, knowledge is not merely useful—it is indispensable. This platform offers access to critical information regarding our product portfolio, the latest developments within the global pharmaceutical sector, essential international regulatory updates, insightful analyses of pharmaceutical, nutraceutical, and herbal products and business processes, comprehensive guides and practical how-tos, and details on upcoming industry events.
Fingolimod, approved in 2010, has been used to treat multiple sclerosis, particularly the relapsing-remitting (RR) form. It is a sphingosine-1-phosphate…
‘Clostridium butyricum’ is an anaerobic, Gram-positive, spore-forming bacillus commonly used to treat several gastrointestinal diseases, inflammation and allergic reactions. It may…
An antibiotic agent commonly used for the treatment of beta-hemolytic streptococcal and pneumococcal infections as well as for staphylococcal infections…